search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
SKIN CARE 145


Figure 2: Schematic representation of the senolytic study concept. The desired senolytic activity depicted on the right results in the depletion of senescent cells while not affecting the healthy cell number.


senolytics has not yet been applied in the cosmetic field despite its great potential for skin rejuvenation.


Protein carbonylation Environmental stress factors, such as UV light, infrared radiation, tobacco smoke, and pollution, generate reactive oxygen species (ROS). ROS oxidise proteins and lipids, which are the main components of cell membranes. This leads to carbonylation, which is one of the most harmful irreversible modifications of protein structure. Under normal conditions, the resulting carbonylated proteins are recycled by the proteasome. However, age and an increase in oxidative stress factors impair the proteasome activity, which leads to a further addition of lipid aldehydes to these carbonylated proteins resulting in their crosslinking. These high-molecular-weight superstructures resist degradation and accumulate over time, and they become cytotoxic and accelerate ageing by promoting cellular senescence. Therefore, the content of carbonylated proteins is the major indicator of oxidative damage and a hallmark of ageing.


An extract from organic Swiss alpine rose leaves Rhododendron ferrugineum, which is also known as alpine rose, is one of the most typical and iconic plants of the Swiss Alps. To produce an active ingredient for cosmetics, the leaves of alpine roses were handpicked by organic farmers in the Swiss Alps through controlled wildcrafting. The extract from these leaves (INCI: Rhododendron Ferrugineum Extract (and) Glycerin (and) Aqua / Water, from here on alpine rose extract) inhibits the formation of carbonylated proteins and


April 2020


therefore protects the skin against the formation of premature senescent cells. Where cellular senescence has already occurred, the alpine rose extract can help to clear these cells from the tissue thanks to its senolytic activity.


Materials and methods Senolytic assay In order to distinguish between the prevention of senescence and true senolytic activity, Normal Human Dermal Fibroblasts were first stressed with 500 µM H2


O2 for 2


hours to induce premature senescence through oxidative stress. The medium was then exchanged, and the cells were grown for 3 days to fully establish the senescent phenotype in a subpopulation of the cells. This mixture of senescent and healthy fibroblasts was then treated for 48 hours with


n Senescent fibroblasts n Healthy fibroblasts


120 100 80 60 40 20 0


Control * **


20 15 10 5 0


Navitoclax 3 uM


1% Alpine Rose Extract


*p<0.005 versus control **p<0.0005 versus control


-10


Figure 3: The alpine rose extract exhibits senolytic activity. Cell numbers of senescent and non-senescent cells are shown normalised to control cells in which senescence was induced with hydrogen peroxide.


*p<0.05 versus placebo


Figure 4: Prevention of protein carbonyl formation by the alpine rose extract upon UVA stress in vivo.


PERSONAL CARE EUROPE -5 *


either 1% alpine rose extract or Navitoclax (Cayman Chemical, Ann Arbor, USA), a known senolytic drug, or not treated (control). Following fixation with 2% formaldehyde and 0.2% glutaraldehyde, cells were stained with DAPI and the relative total cell number was determined by fluorescence measurement. Senescence-Associated β-galactosidase activity assay was performed according to (6) and a total of 400 cells were counted. Counting the β-gal-positive cells as a marker for senescence and calculating the percentage compared to the total cell number revealed the treatment efficacy.


In vivo protein carbonylation assay A double-blind, placebo-contolled clinical study was performed with 12 volunteers (9 female/3 male, 40 - 54 years) who applied a placebo cream and 2% alpine rose extract in


n Placebo n 2% Alpine Rose Extract


Cell number compared to control cells (=100) in %


Carbonyl protein concentration compared to unirradiated/untreated


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196